Chemomab Therapeutics (CMMB) Cash from Operations (QoQ) (2018 - 2023)
Chemomab Therapeutics (CMMB) Cash from Operations (QoQ) (2018 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Chemomab Therapeutics |
852.08 Mn |
841.71 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
28.82% |
| Sep 30, 2023 |
30.24% |
| Jun 30, 2023 |
-4.17% |
| Mar 31, 2023 |
-26.00% |
| Dec 31, 2022 |
-8.53% |
| Sep 30, 2022 |
7.82% |
| Jun 30, 2022 |
-53.62% |
| Mar 31, 2022 |
-28.23% |
| Dec 31, 2021 |
-12.17% |
| Sep 30, 2021 |
53.99% |
| Jun 30, 2021 |
-333.64% |
| Mar 31, 2021 |
16.85% |
| Dec 31, 2020 |
-72.59% |
| Sep 30, 2020 |
-3.21% |
| Jun 30, 2020 |
54.36% |
| Mar 31, 2020 |
67.65% |
| Dec 31, 2019 |
-68.63% |
| Sep 30, 2019 |
10.42% |
| Jun 30, 2019 |
-25.40% |
| Mar 31, 2019 |
11.33% |
